Related Experiment Video
Updated: Jun 23, 2026
07:40
Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders
Published on: April 14, 2017
Engineering brain organoids: from neurodevelopmental modeling to translational barriers
1Department of Medical Technology and Clinical Engineering, Faculty of Medical Technology and Clinical Engineering, Gunma University of Health and Welfare, 191-1 Kawamagari-cho, Maebashi City, Gunma, 371-0823, Japan. y-nishi@kitasato-u.ac.jp.
Summary
Brain organoids are advancing as complex models of human neurodevelopment and disease. Innovations enhance their utility, but ethical considerations and standardization are key for future therapeutic applications.
Area of Science:
- Neuroscience
- Bioengineering
- Developmental Biology
Background:
- Brain organoids have evolved into sophisticated models of human neurodevelopment and disease.
- Current limitations include challenges in maturation, vascular integration, reproducibility, and standardization.
Purpose of the Study:
- To review recent innovations in brain organoid technology.
- To discuss the potential and challenges of brain organoids for translational research.
- To highlight the future directions for bioengineered neural systems.
Main Methods:
- Review of recent innovations such as microfluidic perfusion, synthetic matrices, vascularization, and assembloid assembly.
- Discussion of advancements in creating functionally integrated and controllable neural systems.
Main Results:
- Innovations are shifting brain organoid development from descriptive modeling to functional integration.
- New strategies improve experimental control and biological fidelity.
- Ethical and regulatory considerations are increasingly important.
Conclusions:
- Brain organoids are emerging as powerful bioengineered neural tissue systems.
- Balancing biological fidelity with experimental utility is crucial for future progress.
- Advances in standardization and systems integration are essential for maximizing translational impact in disease modeling, therapeutics, and regenerative neuroscience.
